ArticleCureus2023
Solitary Neurofibroma of the Maxillary Soft Tissue Causing Bone Destruction: A Rare Presentation.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
- Unraveling a Hidden Mass: A 10-Year Mystery of Groin Swelling Reveals an Unexpected Diagnosis of Neurofibroma.Clinical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurofibroma is a benign tumor of the peripheral nerve. It usually presents as multiple tumors and as a part of von Recklinghausen's disease. However, rarely, it can occur in solitary form. The clinical diagnosis of solitary neurofibroma poses a challenge to clinicians as a plethora of benign and malignant lesions of the oral cavity have similar clinical presentations. We present a rare case of solitary neurofibroma of the maxillary soft tissue. A systemic clinical examination was performed to rule out neurofibromatosis. Computed tomography showed displaced teeth and bone destruction. Magnetic resonance imaging showed an ill-defined T2 hyperintense lesion involving the posterior aspect of the tooth-bearing alveolar process of the maxilla. The diagnosis of neurofibroma was confirmed by histological analysis and immunohistochemical studies. The tumor was successfully managed with excision. Three years of follow-up showed no recurrence. Solitary neurofibroma of the oral cavity is a very rare presentation. Neurofibroma in the maxilla with bone destruction is reported for the first time in the literature. This article will add to the current literature due to the atypical location and presentation of the tumor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.